Two Children’s Medical Center Research Institute at UT Southwestern (CRI) scientists have been named to Clarivate’s 2024 Highly Cited Researcher list: Sean J. Morrison, Ph.D., and Ralph J. DeBerardinis, M.D., Ph.D.
This is the seventh year in a row Drs. Morrison and DeBerardinis have been on the analytic company’s annual list, which highlights individuals who “demonstrate significant and broad influence in research.” Listed researchers have authored papers that rank in the top 1% by citations for their field and publication year, from within Clarivate’s “Web of Science Core Collection,” across the past decade — although citation activity is not the sole indicator.
Drs. Morrison and DeBerardinis were recognized for their advances to the “Molecular Biology and Genetics” field.
About Sean J. Morrison, Ph.D.
Dr. Morrison has been Director of CRI since its inception in 2011 and a Howard Hughes Medical Institute (HHMI) Investigator since 2000. His research lab aims to better understand the mechanisms that maintain adult tissues and how cancer cells hijack these mechanisms to enable the formation of tumors.
He was elected to the European Molecular Biology Organization in 2023, the U.S. National Academy of Sciences in 2020, and the U.S. National Academy of Medicine in 2018. He served as president of the International Society for Stem Cell Research (ISSCR) in 2015-2016 and is currently chair of the ISSCR Public Policy Committee.
Dr. Morrison holds the Kathryne and Gene Bishop Distinguished Chair in Pediatric Research at CRI. He is also Professor of Pediatrics at UT Southwestern and holds Mary McDermott Cook Chair in Pediatric Genetics. He is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research and member of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern.
About Ralph J. DeBerardinis, M.D., Ph.D.
Dr. DeBerardinis is Professor and Director of the Eugene McDermott Center for Human Growth and Development / Center for Human Genetics at UT Southwestern, as well as Professor in CRI. His research lab studies the intersection of metabolism, genetics, pediatric inborn errors and cancer.
Dr. DeBerardinis has been a HHMI Investigator since 2018. He is Director of CRI’s Genetic and Metabolic Disease Program and co-leads the Cellular Networks in Cancer Research Program of the Simmons Cancer Center. A pediatrician by trade, Dr. DeBerardinis was elected into the National Academy of Medicine and Association of American Physicians in 2020.
Dr. DeBerardinis holds the Eugene McDermott Distinguished Chair for the Study of Human Growth and Development and the Philip O’Bryan Montgomery Jr., M.D., Distinguished Chair in Developmental Biology, and is a Sowell Family Scholar in Medical Research.